These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3464137)

  • 1. Isolation and identification of metabolites of ofloxacin in rats, dogs and monkeys.
    Sudo K; Okazaki O; Tsumura M; Tachizawa H
    Xenobiotica; 1986 Aug; 16(8):725-32. PubMed ID: 3464137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-week sub-acute toxicity study of S-(-)-9-fluoro-2,3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl)-7-oxo-7H-pyrido-[1,2,3,-de] [1,4]benzoxazine-6- carboxylic acid hemihydrate (DR-3355) in CD rats and cynomolgus monkeys.
    Kato M; West HA; Ashby R; Virgo DM; Fowler JS; Furuhama K; Takayama S
    J Toxicol Sci; 1991 Feb; 16(1):29-48. PubMed ID: 1895350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H- pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin).
    Mitscher LA; Sharma PN; Chu DT; Shen LL; Pernet AG
    J Med Chem; 1987 Dec; 30(12):2283-6. PubMed ID: 2824776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ofloxacin after parenteral and oral administration.
    Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1338-42. PubMed ID: 3479046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
    Okuyama Y; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute oral toxicity of the new quinolone antibacterial agent levofloxacin in mice, rats and monkeys.
    Kato M; Furuhama K; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):365-6. PubMed ID: 1622433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biotransformation of selected gyrase inhibitors].
    Borner K; Lode H
    Infection; 1986; 14 Suppl 1():S54-9. PubMed ID: 3007367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-six-week oral toxicity of the new quinolone antibacterial agent levofloxacin in rats and cynomolgus monkeys.
    Kato M; Furuhama K; Woolley AP; Ashby R; Fowler JS; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):367-73. PubMed ID: 1622434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LD50 value, phototoxicity and convulsion induction test of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acid hemihydrate in laboratory animals.
    Shimoda K; Akahane K; Nomura M; Kato M
    Arzneimittelforschung; 1996 Jun; 46(6):625-8. PubMed ID: 8767355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antibacterial activities of optically active ofloxacin.
    Hayakawa I; Atarashi S; Yokohama S; Imamura M; Sakano K; Furukawa M
    Antimicrob Agents Chemother; 1986 Jan; 29(1):163-4. PubMed ID: 3460520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycoplasmal activities of (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10 -[4-(2-pyridyl)-1-piperazinyl]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine -6-carboxylic acid (YH-6) in comparison with other antibiotics in vitro.
    Ye H; Wu JM; Yang YS; Ji RY; Chen KX
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1031-4. PubMed ID: 11270970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycoplasmal activity of ofloxacin (DL-8280).
    Osada Y; Ogawa H
    Antimicrob Agents Chemother; 1983 Mar; 23(3):509-11. PubMed ID: 6573869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on metabolism of pyridonecarboxylic acid. I. Isolation and identification of metabolites of (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluenesulfonate hydrate (T-3262) in urine].
    Tai M; Konishi Y; Sugimoto Y; Demachi K; Maeda T
    Jpn J Antibiot; 1989 Apr; 42(4):868-75. PubMed ID: 2769939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 5th communication: isolation and identification of metabolites of imidapril in rats, dogs, and monkeys.
    Yamada Y; Ohashi R; Sugawara Y; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):490-8. PubMed ID: 1642672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive toxicity of ofloxacin.
    Takayama S; Watanabe T; Akiyama Y; Ohura K; Harada S; Matsuhashi K; Mochida K; Yamashita N
    Arzneimittelforschung; 1986 Aug; 36(8):1244-8. PubMed ID: 3465327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on metabolism of pyridonecarboxylic acid II. Determination of metabolites of (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4-difluorophenyl)- 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluenesulfonate hydrate (T-3262) in blood, urine, bile, and feces].
    Tai M; Sakai H; Nitta J; Hayakawa H; Sugimoto Y; Hayashi K; Maeda T
    Jpn J Antibiot; 1989 Apr; 42(4):876-86. PubMed ID: 2769940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of 6,8-difluoro-1-(2-fluoroethyl)-1,4- dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid and its metabolites in laboratory animals.
    Kusajima H; Ooie T; Kawahara F; Uchida H
    J Chromatogr; 1986 Aug; 381(1):137-48. PubMed ID: 3095363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-month oral toxicity study of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)-9-fluoro-2,3-dihydro-3- methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid hemihydrate in rats and cynomolgus monkeys.
    Sugawara T; Yoshida M; Shimoda K; Takada S; Miyamoto M; Nomura M; Kato M
    Arzneimittelforschung; 1996 Jul; 46(7):705-10. PubMed ID: 8842343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.